Brief: Renovorx Announces Pricing Of $12.1 Million Underwritten Public Offering Of Common Stock
07/02/2025 01:50
Feb 6 (Reuters) - RenovoRx Inc RNXT.O :
* RENOVORX ANNOUNCES PRICING OF $12.1 MILLION UNDERWRITTEN
PUBLIC
OFFERING OF COMMON STOCK
* RENOVORX INC - PRICING PUBLIC OFFERING OF 11,523,810
SHARES OF
ITS COMMON STOCK AT A PRICE TO PUBLIC OF $1.05 PER SHARE
Source text: ID:nBwbNfb11a
Further company coverage: RNXT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on RenovoRx
See all newsBrief: Renovorx Advances Tamp Into Borderline Resectable Pancreatic Cancer With First Patient Enrolled In Investigator-Initiated Prism-Tamp Trial
RenovoRx Inc reports results for the quarter ended June 30 - Earnings Summary
Oncology device maker RenovoRx's Q2 revenue surges, raises FY outlook
Brief: RenovoRx Q2 Net Income USD -2.911 Million
Brief: Renovorx Achieves Major Milestone With Full Enrollment In Phase Iii Tiger-Pac Trial For Locally Advanced Pancreatic Cancer